Low Dose Bismuth Versus Lactobacillus Reuteri for H. Pylori Eradication

• Status: Terminated
• Trial end date: 2018-12-23
• Target enrollment: 0
• Participant gender: All

Summary

This study investigates the efficacy of a b.i.d. quadruple therapy containing Pylera® or L. reuteri for H. pylori infection.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Università degli Studi di Sassari
• Treatments: Bismuth; Bismuth tripotassium dicitrate; Metronidazole; Pantoprazole; Tetracycline

Criteria

Inclusion Criteria:

• Positive for H. pylori infection

Exclusion Criteria:

• Presence of malignancy

• Pregnancy or lactation

• Clinically significant diseases

• History of drug or alcohol abuse

• Allergy to pantoprazole or to any component of regimens used in the study

• Use of anti-secretory drugs, antibiotics or probiotics 4 weeks preceding the enrollment.